This
paper reports an active decapeptide inhibitor (RR: RYYAAFFARR)
of β-amyloid (Aβ1–40) aggregation. Traditional
inhibitors target the hydrophobic core of Aβ (Aβ16–20) and were designed based on the single hydrophobic interaction.
RR was designed to target an extended region (Aβ11–23), which contains three important regions of Aβ1–40. RR exhibits stronger binding affinity for Aβ1–40 (KD = 1.10 μM) than the known
β-sheet breaker LPFFD (KD = 156
μM). Our study shows that RR inhibited the fibrillation of Aβ1–40 by nearly 75% at an equimolar concentration, and
that a 1:4 ratio of Aβ1–40/ RR almost completely
inhibited fibrillation. The interaction mechanism was also investigated
by changing the ionic strength or the structure of RR. The results
revealed that RR binds to Aβ1–40 because of
its strong affinity for Aβ11–23, which is
mainly driven by hydrophobic and electrostatic interactions and hydrogen
bonding.